Management of hepatocellular carcinoma: an overview of major findings from meta-analyses

Xingshun Qi; Yan Zhao; Hongyu Li; Xiaozhong Guo; Guohong Han

doi:10.18632/oncotarget.9157

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Management of hepatocellular carcinoma: an overview of major findings from meta-analyses

Xingshun Qi _, Yan Zhao, Hongyu Li, Xiaozhong Guo and Guohong Han

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:34703-34751. https://doi.org/10.18632/oncotarget.9157

Metrics: PDF 2706 views | HTML 3247 views | ?

Abstract

Xingshun Qi1,2,*, Yan Zhao2,3,*, Hongyu Li1,*, Xiaozhong Guo1, Guohong Han2

1Department of Gastroenterology and Meta-analysis Study Interest Group, General Hospital of Shenyang Military Area, Shenyang, 110840 China

2Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, 710032 China

3Department of Gastroenterology, First Affiliated Hospital of the Medical College, Xi’an Jiaotong University, Xi’an, 710000 China

*Co-first authors, these authors contributed equally to this work

Correspondence to:

Xingshun Qi, email: [email protected]

Xiaozhong Guo, email: [email protected]

Guohong Han, email: [email protected]

Keywords: hepatocellular carcinoma, treatment, management, meta-analysis, systematic review

Received: February 19, 2016 Accepted: April 11, 2016 Published: May 04, 2016

ABSTRACT

This paper aims to systematically review the major findings from meta-analyses comparing different treatment options for hepatocellular carcinoma (HCC). A total of 153 relevant papers were searched via the PubMed, EMBASE, and Cochrane library databases. They were classified according to the mainstay treatment modalities (i.e., liver transplantation, surgical resection, radiofrequency ablation, transarterial embolization or chemoembolization, sorafenib, and others). The primary outcome data, such as overall survival, diseases-free survival or recurrence-free survival, progression-free survival, and safety, were summarized. The recommendations and uncertainties regarding the treatment of HCC were also proposed.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9157

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Management of hepatocellular carcinoma: an overview of major findings from meta-analyses

Abstract